REGN7257 in Adult Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy

NCT04409080 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Severe Aplastic Anemia (SAA)

Interventions

DRUG: REGN7257

Sponsor

Regeneron Pharmaceuticals